###begin article-title 0
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FFAR1</italic>
Variants in the FFAR1 Gene Are Associated with Beta Cell Function
###end article-title 0
###begin p 1
Conceived and designed the experiments: LG CC MK PL. Performed the experiments: MK PL. Analyzed the data: VL PA MK. Contributed reagents/materials/analysis tools: LG CC. Wrote the paper: LG CC MK PL.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 188 190 188 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 424 429 424 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FFAR1</italic>
The FFAR1 receptor is expressed mainly in pancreatic beta cells and is activated by medium to long chain free fatty acids (FFAs), as well as by thiazolidinediones, resulting in elevated Ca2+ concentrations and promotion of insulin secretion. These properties suggest that FFAR1 could be a mediator of lipotoxicity and a potential candidate gene for Type 2 diabetes (T2D). We therefore investigated whether variations at the FFAR1 locus are associated with T2D and beta cell function.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FFAR1</italic>
###xml 225 230 225 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FFAR1</italic>
###xml 296 304 <span type="species:ncbi:9606">patients</span>
We re-sequenced the FFAR1 region in 96 subjects (48 healthy and 48 T2D individuals) and found 13 single nucleotide polymorphisms (SNPs) 8 of which were not previously described. Two SNPs located in the upstream region of the FFAR1 gene (rs1978013 and rs1978014) were chosen and genotyped in 1929 patients with T2D and 1405 healthy control subjects. We observed an association of rs1978013 and rs1978014 with insulinogenic index in males (p = 0.024) and females (p = 0.032), respectively. After Bonferroni corrections, no association with T2D was found in the case-control material, however a haplotype consisting of the T-G alleles conferred protection against T2D (p = 0.0010).
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 17 22 17 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FFAR1</italic>
Variation in the FFAR1 gene may contribute to impaired beta cell function in T2D.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 151 154 151 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Groop1">[1]</xref>
###xml 155 158 155 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Ahren1">[4]</xref>
###xml 409 412 409 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Manco1">[5]</xref>
###xml 413 416 413 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Robertson1">[7]</xref>
Deterioration of beta cell function is a hallmark of Type 2 diabetes (T2D) and is considered to contribute to worsening of glucose tolerance with time [1]-[4]. While the underlying causes are not fully understood, chronic exposure of beta cells to high concentrations of glucose (glucotoxicity) and free fatty acids (FFAs) (lipotoxicicity) have been suggested to induce irreversible changes in islet function [5]-[7]. The pathways by which glucose enters into beta cells are well described but less is known by which mechanisms elevated FFAs might affect beta cells and their function.
###end p 9
###begin p 10
###xml 228 236 228 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 285 288 285 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Itoh1">[8]</xref>
###xml 289 293 289 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Briscoe1">[10]</xref>
###xml 355 358 355 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Kotarsky1">[9]</xref>
###xml 379 381 379 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 444 449 444 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FFAR1</italic>
###xml 525 529 525 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-2">[11]</xref>
###xml 531 535 531 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Mori1">[12]</xref>
###xml 563 566 563 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Ahren1">[4]</xref>
###xml 568 572 568 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Panhuysen1">[13]</xref>
###xml 766 770 766 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Sawzdargo1">[14]</xref>
###xml 896 899 896 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Itoh1">[8]</xref>
###xml 900 904 900 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Briscoe1">[10]</xref>
###xml 1065 1069 1065 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Latour1">[15]</xref>
###xml 1129 1133 1129 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Steneberg1">[16]</xref>
###xml 1328 1333 1328 1333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FFAR1</italic>
###xml 1390 1395 1390 1395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FFAR1</italic>
###xml 795 801 <span type="species:ncbi:9606">humans</span>
###xml 906 910 <span type="species:ncbi:10090">Mice</span>
###xml 1359 1364 <span type="species:ncbi:9606">human</span>
The free fatty acid receptor FFAR1 (GPR40-G protein-coupled receptor 40) is the first gene product identified to act as an extracellular membrane receptor for FFAs. It was recently shown to be activated in pancreatic beta cells in vitro by medium to long chain free fatty acids (FFAs) [8]-[10] as well as by thiazolidinediones (Rosiglitazone and MCC-555) [9], causing elevated Ca2+ concentrations and subsequent promotion of insulin secretion. FFAR1 is located in the 19q13.1 chromosomal region, which has been linked to T2D [11], [12] and T2D-related phenotypes [4], [13] in several genome wide scans. The open reading frame of the gene encompasses a single exon of 903 bp encoding seven transmembrane domains, characteristic of G protein-coupled receptors (GPCRs) [14]. Studies in rodents and humans have shown that the FFAR1 is expressed mainly in pancreatic beta cells, but also in the brain [8]-[10]. Mice with overexpression of FFAR1 show impaired beta cell function and develop diabetes, whereas disruption of the gene reduces FFA-stimulated insulin release [15] and, according to Steneberg et al., protects from diabetes [16]. These properties make FFAR1 an interesting candidate for mediating lipotoxicity in beta cells although its role in this process is not fully unravelled. To investigate whether variation in the FFAR1 locus is associated with human T2D, we re-sequenced the FFAR1 gene and tested two of the identified SNPs for association with T2D and beta cell function.
###end p 10
###begin title 11
Materials and Methods
###end title 11
###begin title 12
Study subjects
###end title 12
###begin p 13
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FFAR1</italic>
###xml 226 230 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Groop2">[17]</xref>
###xml 45 53 <span type="species:ncbi:9606">patients</span>
To identify SNPs in the FFAR1 region, 48 T2D patients (31 male, 17 females, age 51+/-6, BMI 25.4+/-1.7) and 48 healthy glucose-tolerant control subjects (20 males, 28 females, age 62+/-7, BMI 23.2+/-2.1) from the Botnia study [17] were selected for initial sequence analysis.
###end p 13
###begin p 14
###xml 123 130 123 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001090-t001">Table 1</xref>
###xml 177 182 177 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FFAR1</italic>
###xml 351 358 351 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001090-t001">Table 1</xref>
###xml 360 364 360 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Groop2">[17]</xref>
###xml 54 62 <span type="species:ncbi:9606">patients</span>
The case-control material genotyped consisted of 1929 patients with T2D and 1405 control subjects from Finland and Sweden (Table 1). In addition, we studied whether SNPs in the FFAR1 gene influenced insulin secretion and FFA levels measured during oral glucose tolerance test (OGTT) in 1011 non-diabetic individuals participating in the Botnia study (Table 1) [17]. Study subjects were unrelated except 354 sibling pairs (each pair from different family) included in the cohort of 1011 healthy individuals.
###end p 14
###begin title 15
###xml 28 35 <span type="species:ncbi:9606">patient</span>
Clinical characteristics of patient samples
###end title 15
###begin p 16
###xml 10 17 10 17 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001090-t001">Table 1</xref>
Legend to Table 1. Data are mean+/-SD. ND: not determined.
###end p 16
###begin p 17
###xml 9 17 <span type="species:ncbi:9606">patients</span>
###xml 274 282 <span type="species:ncbi:9606">patients</span>
###xml 334 342 <span type="species:ncbi:9606">patients</span>
1455 T2D patients were measured for C peptide but the rest 451-for fasting plasma insulin (HOMA index was calculated from these). Values of 2 hrs glucose and insulin were obtained for 256 and 251 individual, respectively. Insulinogenic index could be calculated for 192 T2D patients. Blood pressure information was obtained from 1438 patients.
###end p 17
###begin p 18
Values of 2 hrs glucose and insulin, HOMA, insulinogenic index and HDL cholesterol were available only in 68% of the control group but trigliceride values in 87% of the individuals.
###end p 18
###begin p 19
###xml 53 57 53 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Alberti1">[18]</xref>
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Groop2">[17]</xref>
###xml 521 523 521 523 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1c</sub>
###xml 797 811 793 807 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">30 min-fasting</sub>
###xml 820 826 816 822 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">30 min</sub>
###xml 874 878 870 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Matthews1">[19]</xref>
Diagnosis of T2D was based according to WHO criteria [18], GADA negative status and age at onset >35 years (except for three individuals which were below 35 years). Weight, height, plasma glucose, plasma insulin, triglicerides, total cholesterol, HDL cholesterol and blood pressure were measured and oral glucose tolerance test (OGTT) performed as described by Groop et al. [17]; plasma FFA levels were determined using an enzymatic colorimetric method (NEFAC ACS-ACOD Method, Wako Chemicals, Richmond, VA). Haemoglobin A1c (HbA1c) was measured by high-pressure liquid chromatography with a normal range of 4-6% (Diamat Analyzer, Biorad Laboratories, Germany). Body mass index (BMI) was calculated as weight (in kilograms) divided by height (in meters) squared. Insulinogenic index (Delta Insulin 30 min-fasting/Glucose 30 min) and homeostasis model assessment index (HOMA) [19] was used to describe insulin secretion and insulin resistance, respectively. All subjects gave their informed consent at the time of entering to the study, which was approved by local ethics committees at Helsinki and Lund Universities.
###end p 19
###begin title 20
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FFAR1</italic>
Sequencing of FFAR1
###end title 20
###begin p 21
###xml 68 73 68 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FFAR1</italic>
###xml 151 155 151 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-National1">[20]</xref>
###xml 182 187 182 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FFAR1</italic>
###xml 455 473 455 473 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CTCCCCTTCCGGCTCACT</named-content>
###xml 475 497 475 497 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CTCTCCACCATGTCACCTCTTA</named-content>
###xml 522 543 516 537 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CAGGAGTCAAACTCCCATTCC</named-content>
###xml 545 564 539 558 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AGGTGTTGCTGTGGTCCAG</named-content>
###xml 634 652 622 640 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TTGGGCTACCAAGCCTTC</named-content>
###xml 654 672 642 660 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CTGCAGTTCCTCCGAAGC</named-content>
###xml 697 717 679 699 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GTGACCGGTTACTTGGGAAG</named-content>
###xml 719 740 701 722 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CTTTGGGGGAGTCAAAGTCAT</named-content>
A 2379 bp long DNA including the 903 bp of the coding region in the FFAR1 gene was re-sequenced. Reference sequence was taken from the NCBI database ()[20]. In order to sequence the FFAR1 region, four primer pairs of overlapping PCR products were designed using program Primer Premier 5.0 (Premier Biosoft International). Standard protocols for PCR were as follows (5'-3' sequences of forward and reverse primers, product size, annealing temperature): 1) CTCCCCTTCCGGCTCACT, CTCTCCACCATGTCACCTCTTA, 566 bp, 50degreesC; 2) CAGGAGTCAAACTCCCATTCC, AGGTGTTGCTGTGGTCCAG, 901 bp, 62degreesC (designed by MRC Geneservice, Cambridge, UK); 3) TTGGGCTACCAAGCCTTC, CTGCAGTTCCTCCGAAGC, 658 bp, 60degreesC; 4) GTGACCGGTTACTTGGGAAG, CTTTGGGGGAGTCAAAGTCAT, 752 bp, 62degreesC. PCR reactions were performed on GeneAmp PCR System 9700 (Perkin Elmer).
###end p 21
###begin p 22
Sequencing reactions were performed using BigDye v3.1 kit (Applied Biosystems) on GeneAmp PCR System 9700 according to manufacturers protocol. Sequencing products were purified with DyeEx 96 kit (QIAGEN) and run on ABI Prism 3730 Genetic Analyzer (Applied Biosystems). Sequencing data were analyzed with program Sequencher 3.1.2 (Gene Codes Corporation, Ann Arbor, MI, USA).
###end p 22
###begin p 23
Selected SNPs were genotyped using the SNaPshot assay on an ABI 3100 DNA sequencer (Applied Biosystems) according to the manufacturer's protocol.
###end p 23
###begin title 24
Genotyping
###end title 24
###begin p 25
###xml 216 234 206 224 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CTCCCCTTCCGGCTCACT</named-content>
###xml 239 261 229 251 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CTCTCCACCATGTCACCTCTTA</named-content>
###xml 439 459 429 449 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">ACCGTGACATGGATGGGGCC</named-content>
###xml 478 483 468 473 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AACTG</underline>
PCR fragment for the multiplex SNP genotyping of FFAR1 polymorphisms rs1978013 and rs1978014 with SNaPshot assay was amplified in 20 microl reaction volume at an annealing temperature of 55degreesC, primers (5'-3'): CTCCCCTTCCGGCTCACT and CTCTCCACCATGTCACCTCTTA. PCR products were treated with Shrimp Alkaline Phosphatase (SAP) (USB Corporation) and Exonuclease I (New England Biolabs). Extension primer sequence (5'-3') for rs1978013 was ACCGTGACATGGATGGGGCC and for rs1978014-AACTGGGGAGAGCCCAAGGGTCAGC, where the underlined nucleotides indicate an unspecific primer tail included in order to produce differently sized products. The minisequencing reaction was performed on GeneAmp PCR System 9700 according to manufacturer's protocol. After SAP/Exonuclease I treatment, samples where run on ABI Prism 3100 Genetic Analyzer and data analyzed using the GeneMapper 3.1 software (Applied Biosystems).
###end p 25
###begin title 26
Statistical and bioinformatic analysis
###end title 26
###begin p 27
###xml 113 117 113 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Daly1">[21]</xref>
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Barrett1">[22]</xref>
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Eskin1">[23]</xref>
###xml 267 271 267 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Halperin1">[24]</xref>
###xml 347 351 347 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Purcell1">[25]</xref>
###xml 353 357 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Purcell2">[26]</xref>
###xml 1879 1883 1879 1883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Itoh2">[27]</xref>
###xml 1884 1888 1884 1888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Hawkins1">[29]</xref>
###xml 2150 2155 2150 2155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FFAR1</italic>
###xml 2241 2245 2241 2245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Genomatix1">[30]</xref>
###xml 2247 2251 2247 2251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Cartharius1">[31]</xref>
Linkage disequilibrium (LD) calculations and haplotype analysis were carried out using Haploview 3.32 software ()[21], [22]. For haplotype reconstruction and subsequent analysis of metabolic parameters, we used HAP haplotype analysis system available online at [23], [24]. Power calculations were performed online using Genetic Power Calculator ()[25], [26]. Chi-squared test was used to compare the general genotype frequency distribution among T2D and control groups. Odds ratios were calculated using logistic regression analysis with age, BMI and sex as covariates. Mantel-Haenszel test was used to test for heterogeneity between the Swedish and Finnish samples. Differences in insulinogenic index and FFA levels between different genotype carriers were assessed using either ANOVA (for equal weight of genotypes) or linear regression analysis with age, BMI and sex as covariates. A robust variance estimator was used to adjust for the possible non-independence due to family clustering. Correlation between insulin secretion and FFA levels was analysed using multivariate regression correlation matrix (NCSS software). The standard errors were adjusted for repeated measurements made on the same individual by methods of GEE methodology. A p value of <0.05 was considered statistically significant. Bonferroni adjustments for multiple measurements were done were appropriate: p-values were corrected by four in the case-control study (two SNPs tested, stratified by sex), by eight in the phenotype analysis (two SNPs tested for insulinogenic index and post-OGTT FFA levels, stratified by sex) and by eight in the phenotype analysis in haplotypes (four haplotypes tested for insulinogenic index and post-OGTT FFA levels). We chose the additive model as the main hypothesis because it is the model that corresponds better to the putative biological function of FFAR1 receptor [27]-[29]. Therefore p values were not corrected for other genetic models explored (equal weight, recessive and dominant). To correct for multiple testing in the haplotype analysis, 10000 permutations were done using the Haploview software. The 5' upstream region of the FFAR1 gene was analysed for putative regulatory elements using the MatInspector program () [30], [31].
###end p 27
###begin title 28
Results
###end title 28
###begin p 29
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FFAR1</italic>
###xml 446 450 446 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-National1">[20]</xref>
###xml 480 489 480 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001090.s001">Figure S1</xref>
We first re-sequenced a 2379 bp fragment of the FFAR1 region in a screening panel of 96 subjects (48 T2D and 48 healthy subjects). We identified 13 SNPs and two of these polymorphisms where located in the coding region of the gene, including one synonymous (Val) and one non-synonymous (Arg/His, rs2301151) polymorphism. Five of the SNPs (rs1978013, rs1978014, rs10418569, rs2301151 and rs1573611) were previously registered in the NCBI database [20], whereas eight SNPs are new (Figure S1).
###end p 29
###begin p 30
###xml 63 72 63 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001090.s002">Figure S2</xref>
There was no clear linkage disequilibrium between the 13 SNPs (Figure S2). The minor allele frequencies (MAF) of the eight newly discovered SNPs were less then 0.02, the other five SNPs had MAF 0.10-0.48.
###end p 30
###begin p 31
###xml 135 144 135 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001090.s001">Figure S1</xref>
###xml 352 360 <span type="species:ncbi:9606">patients</span>
###xml 582 590 <span type="species:ncbi:9606">patients</span>
Of them, only the frequencies of the two SNPs at positions 598 and 597 bp upstream of the open reading frame (rs1978013 and rs1978014; Figure S1) differed between the T2D and control subjects in the screening panel (rs1978013: 13 TT, 25 TC and 10 CC in T2D vs. 15 TT, 31 TC and 2 CC in controls, p = 0.047 and for rs1978014: 4 AA, 4 AG and 9 GG in T2D patients with BMI<30 vs. 12 AA, 20 AG and 7 GG in control individuals with BMI<30, p = 0.024). These two SNPs were then further tested for association with T2D in a case-control material from Finland and Sweden consisting of 1929 patients with T2D and 1405 control subjects. All genotypes were in Hardy-Weinberg equilibrium, both in cases and in controls.
###end p 31
###begin p 32
###xml 21 25 21 25 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-3">[32]</xref>
###xml 70 71 70 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 130 131 130 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 163 164 163 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 218 219 218 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 248 249 248 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 260 261 260 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 277 286 277 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001090.s002">Figure S2</xref>
The Tagger algorithm [32] of the Haploview software showed that with r2 threshold of 0.3 rs1978013 captures rs10418569 (D' 0.94, r2 0.33) and rs1573611 (D' 0.89, r2 0.31), whereas rs1978014 captures rs10418569 (D' 1, r2 0.28) and rs2301151 (D' 1, r2 0.12) at r2 threshold 0.1 (Figure S2).
###end p 32
###begin p 33
The bioinformatic analysis revealed three potential transcription factor-binding sites in the vicinity of rs1978013 and rs1978014-ATF6 (located -16 to -10 bp or -17 to -11 bp upstream of rs1978013 and rs1978014, respectively), INSM1 (-11 to -3 bp/-12 to -4 bp) and NF-kappaB (+24 to +33 bp/+23 to +32 bp downstream).
###end p 33
###begin p 34
###xml 327 334 327 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001090-t002">Table 2</xref>
###xml 504 512 504 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001090.s003">Table S1</xref>
There was more than 80% power assuming an additive model to detect an OR of 1.32 (p = 0.05) in the case-control material. However, after Bonferroni correction, no odds ratio was significantly associated with T2D. SNP rs1978014 had an OR 1.26 (95% CI 1.00-1.61) for association with T2D (uncorrected p = 0.049, corr. p = 0.196, Table 2), while CC genotype of rs1978013 was more frequent in T2D group only in males (T2D 17.9%, controls 15.5%, OR 1.49, 95% CI 1.07-2.07, uncorr. p = 0.019, corr. p = 0.076; Table S1).
###end p 34
###begin title 35
Genotype frequencies and odds ratios of the rs1978013 and rs1978014
###end title 35
###begin p 36
###xml 10 17 10 17 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001090-t002">Table 2</xref>
Legend to Table 2. Logistic regression results are adjusted for age, sex, BMI and family dependence. Both nominal and the Bonferroni-corrected p-values are shown. NS: not significant.
###end p 36
###begin p 37
###xml 234 241 234 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001090-t003">Table 3</xref>
Haplotype analysis revealed that a haplotype consisting of the T-G alleles (permutated p = 0.001) of SNPs rs1978013 and rs1978014 conferred protection whereas the C-A haplotype conferred increased risk (permutated p = 0.0486) of T2D (Table 3).
###end p 37
###begin p 38
###xml 123 130 123 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001090-t004">Table 4</xref>
###xml 132 140 132 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001090.s003">Table S2</xref>
###xml 309 316 305 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001090-t004">Table 4</xref>
###xml 494 502 484 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001090.s004">Table S2</xref>
###xml 731 738 713 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001090-t005">Table 5</xref>
Post-OGTT FFA concentration did not significantly differ between different genotype carriers after Bonferroni corrections (Table 4, Table S2). Post-OGTT FFA concentration was lower in the CC/CT carriers (223+/-95 mmol/l) vs. the TT genotype (244+/-148 mmol/l) of rs1978013 (uncorr. p = 0.010, corr. p = 0.08, Table 4). After stratification for sex, post-OGTT FFA levels of rs1978013 were lower in males (TT = 268+/-189, TC = 239+/-96, CC = 215+/-102 mmol/l, uncorr. p = 0.012, corr. p = 0.096, Table S2). In addition, the T-G haplotype showed association with post-OGTT FFA levels which disappeared after Bonferroni correction (T-G 231+/-120 vs C-A 225+/-98, T-A 244+/-139, C-G 210+/-89 mmol/l, uncorr. p = 0.021, corr. p = 0.168, Table 5).
###end p 38
###begin p 39
###xml 284 292 276 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001090.s004">Table S2</xref>
###xml 375 382 367 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001090-t004">Table 4</xref>
###xml 400 407 392 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001090-t005">Table 5</xref>
###xml 685 692 669 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001090-t004">Table 4</xref>
###xml 845 852 821 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001090-t005">Table 5</xref>
The rs1978013 was associated with insulinogenic index only in males (TT = 6.2+/-3.8, TC+CC = 5.3+/-3.4, uncorr. p = 0.003, corr. p = 0.024) while rs1978014 was associated with insulinogenic index only in females (GG+AG = 6.4+/-4.7, AA = 5.2+/-2.9, uncorr. p = 0.004, corr. p = 0.032; Table S2). In the whole sample, insulinogenic index was associated neither with genotypes (Table 4) nor haplotypes (Table 5) after Bonferroni corrections were done. Insulin secretion was lower in C allele carriers of rs1978013 (TT = 6.3+/-4.3, TC+CC = 5.6+/-3.8, uncorr. p = 0.010, corr. p = 0.08) and for AA genotype in rs1978014 (GG+AG = 6+/-4.2, AA = 5.3+/-3.2, uncorr. p = 0.030, corr. p = 0.24) (Table 4). The C-A haplotype had the lowest insulinogenic index (C-A 5.5+/-3.7 vs T-G 6.1+/-4.3, T-A 6+/-3.9, C-G 5.8+/-3.8, uncorr. p = 0.008, corr. p = 0.064, Table 5).
###end p 39
###begin title 40
Association of haplotypes with T2D
###end title 40
###begin p 41
###xml 10 17 10 17 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001090-t003">Table 3</xref>
Legend to Table 3. * To correct for multiple testing, 10000 permutations were done.
###end p 41
###begin title 42
Insulinogenic index and post-OGTT FFA levels in different genotype carriers
###end title 42
###begin p 43
###xml 10 17 10 17 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001090-t004">Table 4</xref>
Legend to Table 4. n = 1011. Data are mean+/-SD. Asterisk (*) indicates results from linear regression analysis, adjusted for age, sex, BMI and family dependence. Both nominal and the Bonferroni-corrected p-values are shown. NS: not significant.
###end p 43
###begin title 44
Insulinogenic index and post-OGTT FFA levels in rs1978013-rs1978014 haplotypes
###end title 44
###begin p 45
###xml 10 17 10 17 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001090-t005">Table 5</xref>
Legend to Table 5. n = 1011. Data are mean+/-SD. Scores of the linear regression analysis are reported. Both nominal and the Bonferroni-corrected p-values are shown. NS: not significant.
###end p 45
###begin title 46
Discussion
###end title 46
###begin p 47
###xml 129 134 129 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FFAR1</italic>
###xml 528 529 528 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The key finding of the present study was that rs1978013 and rs1978014 polymorphisms located upstream of the coding region of the FFAR1 gene were associated with beta cell function in males and females respectively, however, due to the loss of statistical significance during Bonferroni corrections-not in the whole sample. Carriers of the CC genotype of rs1978013 had the lowest insulinogenic index and highest risk of T2D (although not significant after Bonferroni correction) but rs1978014 associates with T2D according to chi2 test. Increased T2D risk was discovered in the C-A haplotype carriers of SNPs rs1978013 and rs1978014.
###end p 47
###begin p 48
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FFAR1</italic>
###xml 348 352 348 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Hevener1">[33]</xref>
###xml 715 716 715 716 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 747 748 747 748 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 281 285 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
The different association between the two polymorphisms in the FFAR1 gene and insulin secretion in males and females might suggest that these polymorphisms may affect insulin sensitivity in a sex-specific manner in accordance with the finding of Hevener et al. showing that female rats are protected from lipid-induced reductions in insulin action [33]. We therefore tested this hypothesis by performing gender-specfic analyses of the putative effect of these SNPs on insulin sensitivity (HOMA). There was no association between HOMA and these polymorphisms, neither in the whole cohort nor after stratification for sex (data not shown). Correlation between HOMA and post-OGTT FFA level was also very weak (males: r2 = 0.17, p = 0.0002, females: r2 = 0.20, p = 0). This indicates that sex-specific differences in insulin sensitivity did not influence our results.
###end p 48
###begin p 49
###xml 286 295 286 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001090.s002">Figure S2</xref>
###xml 307 308 307 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Although close to each other, rs1978013 and rs1978014 did not show any LD. This could possibly be explained by a recombination hot spot in this particular gene region. However, rs1978013 and rs1978014 captured the other common polymorphisms in the sequenced DNA region according to D' (Figure S2) at a low r2 threshold 0.1-0.3. In addition to association with T2D in the initial screening panel, lack of LD between the two neighbouring SNPs made these very close nucleotide positions of particular biological interest. The findings rather suggested that both SNPs, rs1978013 and rs1978014, together formed a haplotype, which increased risk of T2D.
###end p 49
###begin p 50
###xml 170 173 170 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Itoh1">[8]</xref>
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Briscoe1">[10]</xref>
###xml 262 267 262 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FFAR1</italic>
###xml 313 317 313 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Ogawa1">[34]</xref>
###xml 319 323 319 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Hamid1">[35]</xref>
###xml 376 381 376 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 457 462 457 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FFAR1</italic>
###xml 525 529 525 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Ogawa1">[34]</xref>
###xml 630 631 630 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 684 693 684 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001090.s002">Figure S2</xref>
FFAR1 was recently described as a cell-surface bound receptor for FFAs making it a candidate to mediate the negative effects of FFAs on beta cell function (lipotoxicity) [8]-[10]. However, two recent studies did not find an association between variations in the FFAR1 coding region and the risk of developing T2D [34], [35]. Despite the lack of an association with T2D, Ogawa et al. found that the Arg211His polymorphism (rs2301151) in the coding region of FFAR1 influenced serum insulin levels in 327 healthy Japanese males [34]. Although this polymorphism is in LD with rs1978013 and rs1978014 according to D' = 1, however the r2 is low (0.08 for rs1978013 and 0.12 for rs1978014) (Figure S2) suggesting an independent association of these two SNPs with insulin secretion.
###end p 50
###begin p 51
###xml 84 88 84 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Saxena1">[36]</xref>
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FFAR1</italic>
###xml 242 247 242 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FFAR1</italic>
###xml 331 335 331 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-2">[11]</xref>
###xml 337 341 337 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Malhotra1">[37]</xref>
###xml 342 346 342 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Elbein1">[40]</xref>
###xml 422 427 422 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FFAR1</italic>
###xml 541 546 541 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FFAR1</italic>
We have also analysed whether any SNPs in the recent whole genome association study [36] would cover the FFAR1 gene. Unfortunately this region was not covered by any informative SNPs on the Affymetrix chip. The 19q13 chromosomal region where FFAR1 is situated has shown linkage with T2D as well as T2D and lipid-related phenotypes [11], [37]-[40]. However, we can only speculate whether the linkage could be attributed to FFAR1 since the density of markers used in those studies is not high enough (approximate interval 7-13 cM) to pinpoint FFAR1 gene as a strong candidate for the reported linkage.
###end p 51
###begin p 52
###xml 91 96 91 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FFAR1</italic>
###xml 103 108 103 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FFAR1</italic>
###xml 208 212 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-LankatButtgereit1">[41]</xref>
###xml 214 218 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Svoboda1">[42]</xref>
###xml 520 524 520 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Chu1">[43]</xref>
###xml 532 536 532 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Gierl1">[44]</xref>
###xml 551 555 551 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Ho1">[45]</xref>
###xml 951 956 951 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FFAR1</italic>
###xml 995 999 995 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001090-Tomita1">[46]</xref>
###xml 1036 1041 1036 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FFAR1</italic>
###xml 971 976 <span type="species:ncbi:9606">human</span>
Little is known about the promoter structure and transcription factor binding sites of the FFAR1 gene. FFAR1 lacks a canonical TATA box, consistent with reports of other TATA-less G protein-coupled receptors [41], [42]. The rs1978013 and rs1978014 polymorphisms apparently do not directly affect any potential transcription factor-binding motif. However, by sequence analysis, we identified three potential binding motifs for transcription factors which could be implicated in T2D development or beta cell function-ATF6 [43], INSM1 [44] and NF-kappaB [45] in close vicinity to rs1978013 and rs1978014. We can therefore not exclude the possibility that polymorphisms in the rs1978013 and rs1978014 might affect FFAR1 expression by altering transcription or they might be in linkage disequilibrium with another polymorphism affecting FFAR1 expression or function. Recently, Tomita et al. reported that insulinogenic index positively correlated with the FFAR1 mRNA level in human pancreatic islets [46], however, whether variations in the FFAR1 gene induce up- or down regulation of gene expression remains unknown. Identification of regulatory region and subsequent functional studies are necessary to understand the hypothetical effect of rs1978013 and rs1978014 variants on FFAR1 expression levels.
###end p 52
###begin p 53
In summary, our study suggests an effect of polymorphisms in the FFAR1 gene on insulin secretion during an OGTT thereby making it a potential candidate to mediate lipotoxicicty in T2D.
###end p 53
###begin title 54
Supporting Information
###end title 54
###begin p 55
The sequenced region with the detected SNP positions. A 2379 bp long DNA sequence including the 903 bp of the coding region (underlined) in the FFAR1. Five SNPs (framed-rs1978013, rs1978014, rs10418569, rs2301151 and rs1573611) were registered in the NCBI database before, whereas eight (highlited) were not. The rs1978013 and rs1978014 SNPs are located at position 208 and 209, respectively.
###end p 55
###begin p 56
(0.06 MB TIF)
###end p 56
###begin p 57
Click here for additional data file.
###end p 57
###begin p 58
LD structure of the sequenced FFAR1 region. SNPs are numbered according to their position in the sequenced region, nucleotide position 208 and 209 correspond to rs1978013 and rs1978014, respectively, and positions 592, 1437 and 2059-to rs10418569, rs2301151 (Arg211His) and rs1573611, respectively.
###end p 58
###begin p 59
(0.94 MB TIF)
###end p 59
###begin p 60
Click here for additional data file.
###end p 60
###begin p 61
Sex-specific genotype frequencies and odds ratios of the rs1978013. Logistic regression results are adjusted for age, sex, BMI and family dependence. Both nominal and the Bonferroni-corrected p-values are shown. NS: not significant.
###end p 61
###begin p 62
(0.04 MB DOC)
###end p 62
###begin p 63
Click here for additional data file.
###end p 63
###begin p 64
Insulinogenic index and post-OGTT FFA levels in different genotype carriers stratified for sex. Males: n = 475, females: n = 536. Data are mean+/-SD. Asterisk (*) indicates results from linear regression analysis, adjusted for age, BMI and family dependence. Both nominal and the Bonferroni-corrected p-values are shown. NS: not significant.
###end p 64
###begin p 65
(0.05 MB DOC)
###end p 65
###begin p 66
Click here for additional data file.
###end p 66
###begin p 67
We thank Johan Holmkvist, Marketa Sjogren, Margareta Svensson, Anna Berglund, Nael Shaat and Hemang Parikh for support and technical help, Holger Luthman, Bjorn Olde and Christer Owman for valuable discussions and suggestions and the SWEGENE Profiling Polygenic Disease facility for the possibility to use the ABI Prism 3730 genetic analyser.
###end p 67
###begin title 68
References
###end title 68
###begin article-title 69
Pathogenesis of type 2 diabetes: the relative contribution of insulin resistance and impaired insulin secretion.
###end article-title 69
###begin article-title 70
Beta-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities.
###end article-title 70
###begin article-title 71
Beta- and alpha-cell dysfunction in type 2 diabetes.
###end article-title 71
###begin article-title 72
Type 2 diabetes, insulin secretion and beta-cell mass.
###end article-title 72
###begin article-title 73
Effects of dietary fatty acids on insulin sensitivity and secretion.
###end article-title 73
###begin article-title 74
Beta-cell failure in the pathogenesis of type 2 diabetes mellitus.
###end article-title 74
###begin article-title 75
Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes.
###end article-title 75
###begin article-title 76
Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40.
###end article-title 76
###begin article-title 77
###xml 2 7 <span type="species:ncbi:9606">human</span>
A human cell surface receptor activated by free fatty acids and thiazolidinedione drugs.
###end article-title 77
###begin article-title 78
The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids.
###end article-title 78
###begin article-title 79
A genome-wide scan in type 2 diabetes mellitus provides independent replication of a susceptibility locus on 18p11 and suggests the existence of novel Loci on 2q12 and 19q13.
###end article-title 79
###begin article-title 80
Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate Loci on 7p and 11p.
###end article-title 80
###begin article-title 81
###xml 64 71 <span type="species:ncbi:9606">persons</span>
A genome scan for loci linked to quantitative insulin traits in persons without diabetes: the Framingham Offspring Study.
###end article-title 81
###begin article-title 82
###xml 24 29 <span type="species:ncbi:9606">human</span>
A cluster of four novel human G protein-coupled receptor genes occurring in close proximity to CD22 gene on chromosome 19q13.1.
###end article-title 82
###begin article-title 83
GPR40 is necessary but not sufficient for fatty acid stimulation of insulin secretion in vivo.
###end article-title 83
###begin article-title 84
###xml 102 107 <span type="species:ncbi:10090">mouse</span>
The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse.
###end article-title 84
###begin article-title 85
Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects.
###end article-title 85
###begin article-title 86
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.
###end article-title 86
###begin article-title 87
###xml 130 133 <span type="species:ncbi:9606">man</span>
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
###end article-title 87
###begin article-title 88
NCBI.
###end article-title 88
###begin article-title 89
Haploview.
###end article-title 89
###begin article-title 90
Haploview: analysis and visualization of LD and haplotype maps.
###end article-title 90
###begin article-title 91
HAP haplotype analysis system.
###end article-title 91
###begin article-title 92
Haplotype reconstruction from genotype data using Imperfect Phylogeny.
###end article-title 92
###begin article-title 93
Genetic Power Calculator.
###end article-title 93
###begin article-title 94
Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits.
###end article-title 94
###begin article-title 95
GPR40, a free fatty acid receptor on pancreatic beta cells, regulates insulin secretion.
###end article-title 95
###begin article-title 96
Partial expression of the lpr locus in the heterozygous state: presence of autoantibodies.
###end article-title 96
###begin article-title 97
###xml 53 57 <span type="species:ncbi:10090">mice</span>
Development and degeneration of retina in rds mutant mice: photoreceptor abnormalities in the heterozygotes.
###end article-title 97
###begin article-title 98
MatInspector.
###end article-title 98
###begin article-title 99
MatInspector and beyond: promoter analysis based on transcription factor binding sites.
###end article-title 99
###begin article-title 100
Efficiency and power in genetic association studies.
###end article-title 100
###begin article-title 101
###xml 7 11 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Female rats do not exhibit free fatty acid-induced insulin resistance.
###end article-title 101
###begin article-title 102
###xml 108 111 <span type="species:ncbi:9606">men</span>
GPR40 gene Arg211His polymorphism may contribute to the variation of insulin secretory capacity in Japanese men.
###end article-title 102
###begin article-title 103
###xml 50 55 <span type="species:ncbi:9606">human</span>
Studies of relationships between variation of the human G protein-coupled receptor 40 Gene and Type 2 diabetes and insulin release.
###end article-title 103
###begin article-title 104
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.
###end article-title 104
###begin article-title 105
Meta-analysis of genome-wide linkage studies of quantitative lipid traits in families ascertained for type 2 diabetes.
###end article-title 105
###begin article-title 106
Genome-wide linkage scans for fasting glucose, insulin, and insulin resistance in the National Heart, Lung, and Blood Institute Family Blood Pressure Program: evidence of linkages to chromosome 7q36 and 19q13 from meta-analysis.
###end article-title 106
###begin article-title 107
Assessment of genetic linkage and parent-of-origin effects on obesity.
###end article-title 107
###begin article-title 108
Quantitative trait linkage analysis of lipid-related traits in familial type 2 diabetes: evidence for linkage of triglyceride levels to chromosome 19q.
###end article-title 108
###begin article-title 109
###xml 83 88 <span type="species:ncbi:9606">human</span>
Cloning and characterization of the 5' flanking sequences (promoter region) of the human GLP-1 receptor gene.
###end article-title 109
###begin article-title 110
Glucose regulation of the expression of the glucagon receptor gene.
###end article-title 110
###begin article-title 111
Activating transcription factor 6 (ATF6) sequence polymorphisms in type 2 diabetes and pre-diabetic traits.
###end article-title 111
###begin article-title 112
The zinc-finger factor Insm1 (IA-1) is essential for the development of pancreatic beta cells and intestinal endocrine cells.
###end article-title 112
###begin article-title 113
Antioxidants, NFkappaB activation, and diabetogenesis.
###end article-title 113
###begin article-title 114
###xml 106 112 <span type="species:ncbi:9606">humans</span>
Expression of the gene for a membrane-bound fatty acid receptor in the pancreas and islet cell tumours in humans: evidence for GPR40 expression in pancreatic beta cells and implications for insulin secretion.
###end article-title 114
###begin p 115
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 115
###begin p 116
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was supported by UMAS Foundations, Diabetes Program at Lund University, Albert Pahlssons Foundation, Swedish Research Council, Sigrid Juselius Foundation, Folkhalsan Research Foundation and Swedish Diabetes Research Foundation. CMC is supported by Juvenile Diabetes Research Foundation (Grant 11-2004-38).
###end p 116

